EVAN LEVINE Insider Trading $SVRA Savara Inc
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for EVAN LEVINE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of EVAN LEVINE. EVAN LEVINE is CEO & President in Mast Therapeutics, Inc. ($MSTX).
EVAN LEVINE in Savara Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of EVAN LEVINE: CEO & President
Holdings: 4,390,000 shares
Current Value: $614,600
Latest Transaction: Apr 15 2008
$SVRA Market Capitalization: $32.99M
$SVRA Previous Close: $0.14
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of EVAN LEVINE in Savara Inc
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 0.42 | 2,000 | 840 | 4,390,000 | 4.4 M to 4.4 M (+0.05 %) |
| Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 0.43 | 3,000 | 1,290 | 4,388,000 | 4.4 M to 4.4 M (+0.07 %) |
| Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 0.42 | 5,000 | 2,100 | 4,385,000 | 4.4 M to 4.4 M (+0.11 %) |
| Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Sell | S | 0.59 | 3,000 | 1,770 | 4,380,000 | 4.4 M to 4.4 M (-0.07 %) |
| Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Sell | S | 0.60 | 100 | 60 | 4,383,000 | 4.4 M to 4.4 M (0.00 %) |
| Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Sell | S | 0.60 | 900 | 541 | 4,383,100 | 4.4 M to 4.4 M (-0.02 %) |
| Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 2.63 | 1,000 | 2,630 | 4,384,000 | 4.4 M to 4.4 M (+0.02 %) |
| Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Sell | S | 2.82 | 1,000 | 2,820 | 4,383,000 | 4.4 M to 4.4 M (-0.02 %) |
| Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 3.15 | 1,000 | 3,150 | 4,384,000 | 4.4 M to 4.4 M (+0.02 %) |
| Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 4.36 | 1,000 | 4,360 | 4,383,000 | 4.4 M to 4.4 M (+0.02 %) |
| Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 4.47 | 1,000 | 4,470 | 4,382,000 | 4.4 M to 4.4 M (+0.02 %) |
| Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 5.15 | 1,000 | 5,150 | 4,381,000 | 4.4 M to 4.4 M (+0.02 %) |
| Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Sell | S | 4.29 | 2,000 | 8,580 | 4,380,000 | 4.4 M to 4.4 M (-0.05 %) |
| Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 3.87 | 1,000 | 3,870 | 4,382,000 | 4.4 M to 4.4 M (+0.02 %) |
| Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 3.86 | 100 | 386 | 4,381,000 | 4.4 M to 4.4 M (0.00 %) |
| Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 3.86 | 900 | 3,474 | 4,380,900 | 4.4 M to 4.4 M (+0.02 %) |
| Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Sell | S | 3.22 | 1,200 | 3,864 | 4,380,000 | 4.4 M to 4.4 M (-0.03 %) |
| Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Sell | S | 3.16 | 3,800 | 12,008 | 4,381,200 | 4.4 M to 4.4 M (-0.09 %) |
| Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Sell | S | 1.50 | 3,000 | 4,500 | 4,385,000 | 4.4 M to 4.4 M (-0.07 %) |
| Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 0.86 | 1,800 | 1,548 | 4,388,000 | 4.4 M to 4.4 M (+0.04 %) |
| Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 0.93 | 100 | 93 | 4,386,200 | 4.4 M to 4.4 M (0.00 %) |
| Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 0.93 | 400 | 372 | 4,386,100 | 4.4 M to 4.4 M (+0.01 %) |
| Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 0.93 | 100 | 93 | 4,385,700 | 4.4 M to 4.4 M (0.00 %) |
| Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 0.93 | 400 | 372 | 4,385,600 | 4.4 M to 4.4 M (+0.01 %) |
| Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 0.93 | 1,500 | 1,395 | 4,385,200 | 4.4 M to 4.4 M (+0.03 %) |
| Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 0.93 | 500 | 465 | 4,383,700 | 4.4 M to 4.4 M (+0.01 %) |
| Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 0.93 | 100 | 93 | 4,383,200 | 4.4 M to 4.4 M (0.00 %) |
| Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 0.93 | 100 | 93 | 4,383,100 | 4.4 M to 4.4 M (0.00 %) |
| Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 1.19 | 700 | 833 | 4,383,000 | 4.4 M to 4.4 M (+0.02 %) |
| Apr 15 2008 | MSTX | Mast Therapeutics, ... | LEVINE EVAN | CEO & President | Buy | P | 1.19 | 2,300 | 2,737 | 4,382,300 | 4.4 M to 4.4 M (+0.05 %) |
Page: 1